Last reviewed · How we verify
NCT04182061
Internet Transdiagnostic-CBT for Anxiety and Depression in Adolescents
NA trial testing The AMTE protocol in Anxiety Disorder in 60 participants. Completed in 30 September 2023.
30 June 2023
Quick facts
| Lead sponsor | Universidad Nacional de Educación a Distancia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 15 November 2019 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- The AMTE protocol
Conditions studied
- Anxiety Disorder — all drugs for Anxiety Disorder →
- Depressive Disorder — all drugs for Depressive Disorder →
- Emotional Disorder — all drugs for Emotional Disorder →
Sponsor
Universidad Nacional de Educación a Distancia
Who can join
Adults 12 to 18, any sex, with Anxiety Disorder or Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study represents the first research program to assess the efficacy of transdiagnostic cognitive behavior therapy (T-CBT) delivered via internet for anxiety and depression in adolescents. The primary aim of the study was to implement the program AMTE (Aprende a Manejar tus Emociones \[Learn to Manage Your Emotions\]), an internet delivered T-CBT protocol designed to target both anxiety and depression symptoms and disorders (major depression disorder, dysthymic disorder, panic disorder, agoraphobia, generalized anxiety disorder, and social anxiety disorder) in adolescents, and to establish its preliminary efficacy on anxiety and depressive symptomatology. A secondary objective is to demonstrate its potential effect regarding: (a) transdiagnostic measures associated with etiology of emotional disorders including negative affect, anxiety sensitivity, and emotional avoidance, and (b) positive factors including satisfaction with life and positive affect. It is expected that the T-CBT condition will be more effective than the waitlist (WL) control group on the primary (anxiety and depression) and secondary (transdiagnostic and positive factors) outcome measures.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Clinical Utility of an Internet-Delivered Version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (iUP-A): A Pilot Open Trial.
Sandín B, García-Escalera J, Valiente RM, Espinosa V, et al · · 2020 · cited 28× · PMID 33182711 · DOI 10.3390/ijerph17228306 -
Prevention of Depression and Anxiety in Subclinical Adolescents: Effects of a Transdiagnostic Internet-Delivered CBT Program.
Schmitt JC, Valiente RM, García-Escalera J, Arnáez S, et al · · 2022 · cited 23× · PMID 35564759 · DOI 10.3390/ijerph19095365 -
Efficacy of an internet-based version of the unified protocol for transdiagnostic treatment of emotional disorders in adolescents (iUP-A): A randomized active-controlled trial.
Sandín B, Valiente RM, Arnáez S, García-Escalera J, et al · · 2026 · PMID 42064367 · DOI 10.1016/j.invent.2026.100948
Verify or expand the search:
- PubMed search for NCT04182061
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Disorder
Currently open trials in the same condition.
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT07221409 — Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment · NA · recruiting
- NCT07045818 — DLPFC and Sympathetic Reactivity in RPL With Anxiety · recruiting
- NCT05232032 — Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation · Phase 2 · recruiting
- NCT06333925 — Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study · NA · active not recruiting
Other Universidad Nacional de Educación a Distancia trials
Trials by the same sponsor.
- NCT07006220 — Project COPE-Spain (Coping Options for Parent Empowerment) · NA · recruiting
- NCT05771649 — Recovery Strategies Based on Mindfulness and Physical Exercise on Levels of Stress and Inmunoglobulin A · NA · completed
- NCT06894394 — Group Version of the UP-A in a Spanish Day Hospital for Adolescents. · NA · completed
- NCT05654987 — Perinatal Mental Health for Refugee Women · unknown
- NCT06894368 — Group Version of the UP-A in a Spanish Public Mental Health Setting. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04182061 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Nacional de Educación a Distancia
- Last refreshed: 9 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04182061.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing